Table of Contents
Definition / general | Essential features | ICD coding | Epidemiology | Sites | Pathophysiology | Etiology | Diagrams / tables | Clinical features | Diagnosis | Laboratory | Prognostic factors | Case reports | Treatment | Clinical images | Cytology description | Cytology images | Positive stains | Negative stains | Molecular / cytogenetics description | Sample pathology report | Practice question #1 | Practice answer #1 | Practice question #2 | Practice answer #2Cite this page: Chan AWH. Ascites. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/liverascites.html. Accessed April 29th, 2025.
Definition / general
- Ascites is pathological fluid accumulation in the peritoneal cavity
Essential features
- Ascites is pathological fluid accumulation in the peritoneal cavity
- Causes vary in different countries but cirrhosis is the most common cause
- It is the most common major complication of cirrhosis, with a prevalence of 10% among patients
Epidemiology
- It is the most common of the 3 major complications of cirrhosis (ascites, hepatic encephalopathy and bleeding varices) (Hepatology 1987;7:122)
- It is the most common complication of cirrhosis, with a prevalence of 10% among patients (World J Gastroenterol 2022;28:5910)
- 50 - 60% of patients with compensated cirrhosis develop ascites over a 10 year period (Clin Liver Dis 2012;16:285, World J Gastroenterol 2022;28:5910)
Sites
- Peritoneal cavity
Pathophysiology
- Results from a combination of the following factors, which reinforce each other (Clin Liver Dis 2012;16:285)
- Elevated hydrostatic pressure due to portal hypertension
- Reduced osmotic pressure due to hypoalbuminemia
- Renal retention of sodium and water due to activation of renin angiotensin aldosterone system (RAAS)
- Decreased effective circulatory volume due to ascites
Etiology
- Varies in different countries (Clin Chem Lab Med 2023;62:1266)
- In the United States
- Cirrhosis (84.1%)
- Heart failure (2.7%)
- Malignancy (2.4%)
- Tuberculosis (0.7%)
- Pancreatic disease (0.4%)
- In China
- Cirrhosis (30.3%)
- Malignancy (24.2%)
- Tuberculosis (15.9%)
- Pancreatic disease (6.7%)
- Sinusoidal obstruction syndrome (SOS) (4.6%)
- Heart failure (2.7%)
- In the United States
Diagrams / tables
Clinical features
- Abdominal distension with shifting dullness
Diagnosis
- Physical examination: abdominal distension with shifting dullness
- Radiological investigation: ultrasound or computed tomography (CT) scan to detect mild (grade 1) ascites (Hepatology 2021;74:1014)
Laboratory
- Ascitic fluid cell count and differential
- Polymorphonuclear leukocyte (PMN) count > 250 cells/mm3 in the absence of an intra-abdominal, surgically treatable source of infection indicates spontaneous bacterial peritonitis, which complicates ~12% of cirrhotic patients with ascites (Hepatology 1982;2:399, Dig Liver Dis 2001;33:41)
- Serum ascites albumin gradient (SAAG) (Am J Gastroenterol 2009;104:1401)
- ≥ 1.1 g/dL indicates portal hypertension
- < 1.1 g/dL indicates nonportal hypertension causes including malignancies, tuberculous peritonitis and nephrotic syndrome
Prognostic factors
- Ascites is 1 of 5 parameters of the Child-Pugh score, the most widely used system for liver function assessment in cirrhosis (Medicine (Baltimore) 2016;95:e2877)
- Presence of ascites is associated with poorer overall survival in patients with cirrhosis (1 year 85%, 5 year 56%) and hepatocellular carcinoma (Clin Gastroenterol Hepatol 2006;4:1385, Chin J Cancer 2014;33:481)
Case reports
- 39 year old man with eosinophilic ascites due to eosinophilic gastroenteritis (Cureus 2024;16:e68511)
- 54 year old man with ascites due to peritoneal actinomycosis mimicking peritoneal carcinomatosis on positron emission tomography (PET) / CT (Clin Nucl Med 2024;49:1025)
- Woman in her mid-50s with ascites and right pleural effusion due to peritoneal tuberculosis (BMJ Case Rep 2024;17:e263066)
- 63 year old woman with refractory chylous ascites after laparoscopic cholecystectomy (BMC Surg 2022;22:317)
- 64 year old woman with recurrent bloody ascites secondary to heart failure (Medicine (Baltimore) 2022;101:e30708)
Treatment
- First line
- Cessation of alcohol when present
- Sodium restriction
- Dual diuretics (usually spironolactone and furosemide)
- Discontinue nonsteroid anti-inflammatory drugs
- Evaluation for liver transplantation
- Second line
- Discontinue beta blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers
- Serial therapeutic paracentesis
- Transjugular intrahepatic portosystemic stent shunt (TIPSS)
- Evaluation for liver transplantation
- Third line
- Peritoneovenous shunt
- Reference: Hepatology 2021;74:1014
Cytology description
- Only positive in peritoneal carcinomatosis (sensitivity of 96.7% if 3 samples from different paracentesis procedures) (Hepatology 1988;8:1104)
- Almost always negative in cirrhotic patients, even those known to have hepatocellular carcinoma (Cytojournal 2009;6:16)
Cytology images
Positive stains
- Calretinin: differentiating mesothelial cells from metastatic carcinoma (sensitivity 98.5% and specificity 100%) (Acta Cytol 2023;67:257)
- D2-40: differentiating mesothelial cells from metastatic carcinoma (sensitivity 90.4% and specificity 93.8%) (Acta Cytol 2023;67:257)
- BAP1: differentiating reactive mesothelial cells from peritoneal mesothelioma (sensitivity 60 - 70% and specificity 100%) (Arch Pathol Lab Med 2024;148:1251)
- MTAP: differentiating reactive mesothelial cells from peritoneal mesothelioma (sensitivity 5 - 10% and specificity 100%) (Arch Pathol Lab Med 2024;148:1251)
Negative stains
- MOC31: differentiating metastatic carcinoma from mesothelial cells (sensitivity 91.9 - 98.6% and specificity 76.8 - 100%) (Acta Cytol 2023;67:257, Cancer Cytopathol 2023;131:245)
- BerEP4: differentiating metastatic carcinoma from mesothelial cells (sensitivity 55.9 - 91.6% and specificity 93.0 - 100%) (Acta Cytol 2023;67:257, Cancer Cytopathol 2023;131:245)
- Claudin4: differentiating metastatic carcinoma from mesothelial cells (pooled sensitivity 98.0% and pooled specificity 99.7%) (Arch Pathol Lab Med 2025;149:381)
Molecular / cytogenetics description
- CDKN2A homogenous deletion: differentiating peritoneal mesothelioma from reactive mesothelial cells (sensitivity 10 - 15% and specificity 100%) (Arch Pathol Lab Med 2024;148:1251)
- Cell free DNA in ascitic fluid could be a source for next generation sequencing in case of malignant ascites (Cancer Cytopathol 2020;128:43)
Sample pathology report
- Ascitic fluid, cytology:
- Negative for malignant cells
Practice question #1
What is the most common cause of ascites in the United States?
- Cardiac failure
- Cirrhosis
- Malignancy
- Tuberculosis
Practice answer #1
B. Cirrhosis. Over 80% of patients with ascites in the United States are associated with cirrhosis. Answers A, C and D are incorrect because cardiac failure, malignancy and tuberculosis account for 2.7%, 2.4% and 0.7% of cases, respectively (Clin Chem Lab Med 2023;62:1266).
Comment Here
Reference: Ascites
Comment Here
Reference: Ascites
Practice question #2
Practice answer #2
A. Cirrhosis. SAAG ≥ 1.1 g/dL indicates portal hypertension, which is associated with cirrhosis (Am J Gastroenterol 2009;104:1401). Answers B, C and D are incorrect because other causes (malignancy, nephrotic syndrome and tuberculosis) are associated with nonportal hypertension (SAAG < 1.1 g/dL).
Comment Here
Reference: Ascites
Comment Here
Reference: Ascites